---
title: "Baxter International: Business Model"
description: "Baxter International revenue by business segment and geography from its fiscal 2025 Form 10-K, with each part's share, growth and profitability explained."
canonical: https://www.getswoopr.com/stocks/companies/baxter-international/business-model/
source: "Swoopr Investment: https://www.getswoopr.com"
---

# Baxter International: Business Model & Revenue Engine



## Direct Answer

Baxter International reports revenue across 3 business segments in its fiscal 2025 Form 10-K. Medical Products and Therapies is the largest, with $5.3 billion of revenue (47% of the total), followed by Healthcare Systems and Technologies at $3.1 billion (27%). 54% of revenue came from the United States.

## How Does Baxter International Make Money?

No single line supplies a majority of revenue: the largest, Medical Products and Therapies, is 47%, which spreads Baxter International's exposure across several demand drivers. Between fiscal 2024 and 2025, Healthcare Systems and Technologies grew fastest (+4.1%) and Medical Products and Therapies slowest (+1.8%), so the revenue mix tilts toward Healthcare Systems and Technologies while that gap lasts.

| Segment | FY2025 revenue | FY2024 revenue | Share of revenue | Change |
| --- | --- | --- | --- | --- |
| Medical Products and Therapies | $5.3 billion | $5.2 billion | 47.1% | 1.8% |
| Healthcare Systems and Technologies | $3.1 billion | $3.0 billion | 27.3% | 4.1% |
| Pharmaceuticals | $2.5 billion | $2.4 billion | 22.2% | 3.4% |

![Bar chart of Baxter International revenue by segment for fiscal 2025: Medical Products and Therapies 47.1%, Healthcare Systems and Technologies 27.3%, Pharmaceuticals 22.2%.](https://www.getswoopr.com/images/charts/baxter-international-business-model-segment-mix.webp)
*Baxter International revenue by segment as a share of total revenue, from the table above. The largest is highlighted. Select the chart to open it full size.*

## Which Baxter International Segments Earn the Most?

| Segment | FY2025 segment operating income | Segment margin |
| --- | --- | --- |
| Medical Products and Therapies | $970 million | 18.3% |
| Healthcare Systems and Technologies | $441 million | 14.4% |
| Pharmaceuticals | $222 million | 8.9% |

Segment operating income is the profit measure Baxter International reports to its chief operating decision maker for each segment. It usually leaves out corporate costs that are not allocated to a segment, so the segments usually add up to more than consolidated operating income, and margins are comparable within Baxter International more safely than against another company.

## Where Does Baxter International's Revenue Come From?

Regions follow the definitions in the filing; most companies assign revenue by customer location.

| Region | FY2025 revenue | FY2024 revenue | Share of revenue | Change |
| --- | --- | --- | --- | --- |
| United States | $6.1 billion | $5.8 billion | 54.4% | 4.6% |
| Western Europe Canada Japan Australia and New Zealand | $3.7 billion | $3.4 billion | 33.2% | 8.5% |
| Eastern Europe Middle East Africa Latin America Asia | $1.4 billion | $1.4 billion | 12.4% | 3.3% |

## What the Segment Figures Do Not Show

The rows above add up to 97% of Baxter International's reported revenue for fiscal 2025; the difference is intersegment eliminations, corporate revenue or items the company reports outside its segments. Segment definitions are management's choice and change when a company reorganizes, in which case it restates prior years in the next filing, so a multi-year comparison should use the figures from a single filing. Revenue shows where sales come from, not where profit or cash is earned: a small segment can carry most of the margin.

## Where These Numbers Come From

Every figure on this page is a value Baxter International reported in the segment note and revenue disclosures of its Form 10-K filed February 12, 2026 (accession 0001628280-26-007733), read from the SEC's Financial Statement Data Sets. The prior-year column is the comparative figure from that same filing, so it reflects any restatement for a change in segments. Category names are the company's own XBRL labels, lightly reformatted for reading.

Rows that only total other rows (for example a "Products" line beside the individual products) are left out so nothing is counted twice. This page is educational and describes reported history for fiscal 2025; it is not a forecast or a recommendation.

## Frequently Asked Questions

### What are Baxter International's business segments?

In its fiscal 2025 Form 10-K, Baxter International reports revenue for Medical Products and Therapies, Healthcare Systems and Technologies and Pharmaceuticals.

### Which part of Baxter International brings in the most revenue?

Medical Products and Therapies, with $5.3 billion of revenue in fiscal 2025, or 47% of the total.

### How much of Baxter International's revenue comes from outside the United States?

46% in fiscal 2025, by the geographic breakdown Baxter International reports in its Form 10-K. Companies assign revenue to regions differently (customer location, shipping address or selling entity), so check the filing's definition before comparing companies.

## References

- [SEC EDGAR: BAXTER INTERNATIONAL INC Form 10-K filed February 12, 2026](https://www.sec.gov/Archives/edgar/data/10456/000162828026007733/bax-20251231.htm)
- [SEC EDGAR: BAXTER INTERNATIONAL INC annual and quarterly filings](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=10456&type=10-K)
- [SEC: EDGAR application programming interfaces (XBRL frames and submissions data)](https://www.sec.gov/search-filings/edgar-application-programming-interfaces)
- [SEC: Financial Statement Data Sets](https://www.sec.gov/data-research/sec-markets-data/financial-statement-data-sets)

## Related Pages

- [Baxter International company dossier](https://www.getswoopr.com/stocks/companies/baxter-international/)
- [Baxter International financial metrics](https://www.getswoopr.com/stocks/companies/baxter-international/metrics/)
- [Baxter International financial risk indicators](https://www.getswoopr.com/stocks/companies/baxter-international/risks/)
- [Baxter International peer comparison](https://www.getswoopr.com/stocks/companies/baxter-international/competitors/)
- [Baxter International business model and revenue mix](https://www.getswoopr.com/stocks/companies/baxter-international/business-model/)
- [Fundamental analysis guides](https://www.getswoopr.com/learn/fundamental-analysis/)





**[Swoopr Editorial Team](https://www.getswoopr.com/authors/swoopr-editorial-team/)**



Swoopr's editorial team produces independent investment education content reviewed for accuracy and clarity. We do not provide personalized financial advice. See our [editorial policy](https://www.getswoopr.com/legal/editorial-policy/) and [corrections policy](https://www.getswoopr.com/legal/corrections-policy/).